COO
The Cooper Companies, Inc.
COO's fundamentals are mixed, but it looks cheap: trading at 21x earnings, about half its usual 41x. Analysts expect earnings growth.
COO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Stable |
COO's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
COO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $62.19 | — |
| Cheap | 17x | $50.37 | -19% |
| Current | 21x | $62.19 | — |
| Fair | 40x | $117 | +89% |
| Expensive | 61x | $179 | +189% |
Historical ranges are pointers, not guarantees.
COO's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
COO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect COO's earnings to grow and its profitability to improve, with its revenue holding steady.
COO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.64 | +59% |
| Q3 2026 | $2.92 | +43% |
| Q2 2026 | $1.17 | -43% |
| Q1 2026 | $2.01 | -2.9% |
| Q4 2025 | $1.87 | -4.6% |
| Q3 2025 | $2.04 | +14% |
| Q2 2025 | $2.07 | +22% |
| Q1 2025 | $2.07 | +42% |
| Q4 2024 | $1.96 | +32% |
COO's earnings per share have fallen from their peak: $2.92 over the past year, against $14.79 in late 2021.
COO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +0.6% |
| Q2 2026 | $1.1B | +7.9% |
| Q1 2026 | $1B | +6.2% |
| Q4 2025 | $1.1B | +4.6% |
| Q3 2025 | $1.1B | +5.7% |
| Q2 2025 | $1B | +6.3% |
| Q1 2025 | $964.7M | +3.6% |
| Q4 2024 | $1B | +9.8% |
COO's revenue has grown year over year for 23 quarters in a row: $1.1B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +4.3 points |
| Q2 2026 | -2.9% | -21 points |
| Q1 2026 | 21% | +1.9 points |
| Q4 2025 | 13% | -6.3 points |
| Q3 2025 | 17% | -2.6 points |
| Q2 2025 | 18% | +1.3 points |
| Q1 2025 | 19% | +2.4 points |
| Q4 2024 | 19% | +4.8 points |
COO's operating margin was 21% last quarter, up 4.3 points from the same quarter a year ago, near the top of its range since 2019.
COO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $273M | +66% |
| Q2 2026 | $96.4M | +433% |
| Q1 2026 | $158.7M | +57% |
| Q4 2025 | $149.9M | +17% |
| Q3 2025 | $164.5M | +39% |
| Q2 2025 | $18.1M | -51% |
| Q1 2025 | $101.2M | +2100% |
| Q4 2024 | $128.1M | +339% |
COO generated $678M in free cash flow over the past year, up 65% from the year before.
COO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -1.6M shares |
| 1 year | -3.3% | -6.6M shares |
| 3 years | -3.1% | -6.2M shares |
| 5 years | -2.9% | -5.8M shares |
| Available history | -3.3% | -6.6M shares |
COO has 193M diluted shares, down 3.3% from a year ago, with $644M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $339.2M |
| Q2 2026 | $15.5M |
| Q1 2026 | $92.5M |
| Q4 2025 | $196.8M |
| Q3 2025 | $52.7M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
COO spent $644M buying back its own shares over the past year.
COO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.6x | Moderate |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 2.2x | Moderate |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.3x | Moderate |
COO's net debt is about 2.6 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
COO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.3 | Neutral |
| Stochastic | 38.2 | Neutral |
COO's weekly RSI is 46 (neutral) and its Stochastic is 38 (neutral).
COO PE vs Healthcare Sector
| Metric | COO | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 26x | 18% below |
| PE % | 22 | 29 | 7 pts below |
COO is trading at 21x earnings, a 18% discount to the Healthcare sector's median of 26x.
COO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.7 | 5.9% above |
| 20 week MA | $65.3 | 4.7% below |
| 50 week MA | $70.3 | 12% below |
| 100 week MA | $74.3 | 16% below |
| 200 week MA | $83.9 | 26% below |
COO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 26% below its 200-week average.
COO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.3 | $89.6 | +12% |
| 2021 | $89.6 | $102.8 | +15% |
| 2022 | $102.8 | $83.2 | -19% |
| 2023 | $83.2 | $94.6 | +14% |
| 2024 | $94.6 | $92.3 | -2.4% |
| 2025 | $92.3 | $82.6 | -11% |
| 2026 YTD | $82.6 | $62.2 | -25% |
COO has finished lower in three of the last six years. It's down 25% so far in 2026.